Reports for JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE
Brand name
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE
Company Name
JAMP PHARMA CORPORATION
|
Drug Identification Number
02418231 |
Ingredients
HYDROCHLOROTHIAZIDE IRBESARTAN |
Ingredient Strength
12.5 MG 300 MG |
ATC Code
C09DAC09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
CANCELLED POST MARKET
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 28 | Resolved | 2017-03-27 | 2017-09-27 | 4430 |
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 100 | Resolved | 2017-03-27 | 2017-09-27 | 4441 |
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 28 | Actual shortage | 2019-10-11 | 2021-04-05 | 96183 |
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 100 | Actual shortage | 2019-10-11 | 2021-04-05 | 96192 |
Showing 1 to 4 of 4
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0